Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Drug Testing and Analysis|June 20, 2020
Detection of bioactive peptides including gonadotrophin-releasing factors (GnRHs) in horse urine using ultra-high performance liquid chromatography-high resolution mass spectrometry (UHPLC/HRMS)Karen Y Kwok, Timmy L S Choi, Wai Him Kwok, et al.
JCO Oncology Practice|July 17, 2025
Clinical Practice Recommendations for Myelofibrosis Management in the Asia-Pacific Region: The APAC-MF AllianceKeita Kirito, Chul Won Choi, Than Hein, et al.
Annals of Hematology|December 6, 2018
Next-generation sequencing with a 54-gene panel identified unique mutational profile and prognostic markers in Chinese patients with myelofibrosisHarinder Gill, Ho-Wan Ip, Rita Yim, et al.
Therapeutic Advances in Hematology|November 17, 2025
Early measurable residual disease detection post-haematopoietic stem cell transplantation in acute myeloid leukaemiaSze P Tsui, Stephen S Y Lam, Chun H Au, et al.
Blood Cancer Journal|July 31, 2025
A clinico-genomic prognostic model for primary myelodysplastic neoplasm in AsiaHarinder Gill, Rita Yim, Paul Lee, et al.
Cancer|October 4, 2019
Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of Fms-like tyrosine kinase 3Chunxiao Zhang, Stephen S Y Lam, Garret M K Leung, et al.
Clinical and Experimental Medicine|September 25, 2023
Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working GroupHarinder Gill, Garret M K Leung, Melissa G M Ooi, et al.
Blood Advances|December 18, 2024
Acute Promyelocytic Leukemia Asian Consortium study of arsenic trioxide in newly diagnosed patients: impact and outcomeHarinder Gill, Radha Raghupathy, Hsin-An Hou, et al.
Nature Communications|April 6, 2026
Quizartinib and omacetaxine mepesuccinate combination therapy in FLT3-ITD AML: a phase II trialLi-Chuan Zheng, Kelvin K W Wong, Stephen S Y Lam, et al.
Cancer Medicine|March 19, 2020
Clofarabine, cytarabine, and mitoxantrone in refractory/relapsed acute myeloid leukemia: High response rates and effective bridge to allogeneic hematopoietic stem cell transplantationHarinder Gill, Rita Yim, Herbert H Pang, et al.
Pageof 8